Dr. Jens Rueter, MD

NPI: 1891995189
Total Payments
$218.42
2024 Payments
$42.30
Companies
6
Transactions
10

Payment Breakdown by Category

Food & Beverage$218.42 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $218.42 10 100.0%

Top Paying Companies

Company Total Records Latest Year
Incyte Corporation $55.70 3 $0 (2024)
GlaxoSmithKline, LLC. $50.61 2 $0 (2024)
Amgen Inc. $36.90 2 $0 (2023)
E.R. Squibb & Sons, L.L.C. $30.51 1 $0 (2018)
Janssen Biotech, Inc. $29.53 1 $0 (2018)
Millennium Pharmaceuticals, Inc. $15.17 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $42.30 2 GlaxoSmithKline, LLC. ($22.56)
2023 $17.73 1 Amgen Inc. ($17.73)
2022 $64.69 3 GlaxoSmithKline, LLC. ($28.05)
2021 $18.49 1 Incyte Corporation ($18.49)
2018 $60.04 2 E.R. Squibb & Sons, L.L.C. ($30.51)
2017 $15.17 1 Millennium Pharmaceuticals, Inc. ($15.17)

All Payment Transactions

10 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
02/15/2024 GlaxoSmithKline, LLC. JEMPERLI (Biological), ZEJULA Food and Beverage In-kind items and services $22.56 General
Category: ONCOLOGY
01/10/2024 Incyte Corporation JAKAFI (Drug) Food and Beverage Cash or cash equivalent $19.74 General
Category: Hematology/Oncology
09/12/2023 Amgen Inc. Nplate (Biological), Vectibix, XGEVA Food and Beverage In-kind items and services $17.73 General
Category: Hematology
09/13/2022 Amgen Inc. Kyprolis (Drug) Food and Beverage In-kind items and services $19.17 General
Category: Oncology
08/03/2022 Incyte Corporation MONJUVI (Drug), JAKAFI Food and Beverage Cash or cash equivalent $17.47 General
Category: Oncology
01/28/2022 GlaxoSmithKline, LLC. BLENREP (Biological) Food and Beverage In-kind items and services $28.05 General
Category: ONCOLOGY
12/08/2021 Incyte Corporation JAKAFI (Drug) Food and Beverage Cash or cash equivalent $18.49 General
Category: Hematology/Oncology
11/06/2018 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $30.51 General
06/12/2018 Janssen Biotech, Inc. IMBRUVICA (Drug) Food and Beverage In-kind items and services $29.53 General
Category: Oncology
09/05/2017 Millennium Pharmaceuticals, Inc. NINLARO (Drug) Food and Beverage In-kind items and services $15.17 General
Category: Oncology

About Dr. Jens Rueter, MD

Dr. Jens Rueter, MD is a Hematology & Oncology healthcare provider based in Brewer, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1891995189.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jens Rueter, MD has received a total of $218.42 in payments from pharmaceutical and medical device companies, with $42.30 received in 2024. These payments were reported across 10 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($218.42).

Practice Information

  • Specialty Hematology & Oncology
  • Other Specialties Hematology & Oncology
  • Location Brewer, ME
  • Active Since 07/24/2007
  • Last Updated 07/21/2022
  • Taxonomy Code 207RH0003X
  • Entity Type Individual
  • NPI Number 1891995189

Products in Payments

  • JAKAFI (Drug) $38.23
  • IMBRUVICA (Drug) $29.53
  • BLENREP (Biological) $28.05
  • JEMPERLI (Biological) $22.56
  • Kyprolis (Drug) $19.17
  • Nplate (Biological) $17.73
  • MONJUVI (Drug) $17.47
  • NINLARO (Drug) $15.17

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology & Oncology Doctors in Brewer